We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+9.94%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$24.1B
AUM Growth
-$134M
Cap. Flow
-$2.11B
Cap. Flow %
-8.76%
Top 10 Hldgs %
23.77%
Holding
1,984
New
527
Increased
347
Reduced
445
Closed
587

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$157M
2
TMO icon
Thermo Fisher Scientific
TMO
+$135M
3
CRM icon
Salesforce
CRM
+$135M
4
IBM icon
IBM
IBM
+$130M
5
DELL icon
Dell
DELL
+$114M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$313M
2
AAPL icon
Apple
AAPL
+$207M
3
INTC icon
Intel
INTC
+$183M
4
BMY icon
Bristol-Myers Squibb
BMY
+$159M
5
CNC icon
Centene
CNC
+$152M

Sector Composition

Rank Sector Weight
1 Healthcare 23.31%
2 Technology 17.95%
3 Communication Services 13.61%
4 Consumer Discretionary 12.67%
5 Financials 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TLRY icon
976
Tilray
TLRY
$597M
$1.12M ﹤0.01%
6,205
+2,570
+71% +$451K
INTA icon
977
Intapp
INTA
$3.03B
$1.12M ﹤0.01%
+40,000
New +$1.12M
BEP icon
978
Brookfield Renewable
BEP
$9.87B
$1.12M ﹤0.01%
+28,875
New +$1.14M
JWSM.WS
979
CALL
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$1.11M ﹤0.01%
+114,151
New +$131K
VEDL
980
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$1.11M ﹤0.01%
+78,344
New +$1.1M
VERV
981
DELISTED
Verve Therapeutics
VERV
$1.11M ﹤0.01%
+18,451
New +$766K
SBRA icon
982
Sabra Healthcare REIT
SBRA
$5.27B
$1.11M ﹤0.01%
60,914
-73,987
-55% -$1.32M
ULCC icon
983
Frontier Group Holdings
ULCC
$1.61B
$1.1M ﹤0.01%
+64,549
New +$1.27M
CAKE icon
984
Cheesecake Factory
CAKE
$5.46B
$1.09M ﹤0.01%
+20,130
New +$1.16M
TKNO icon
985
Alpha Teknova
TKNO
$345M
$1.09M ﹤0.01%
+45,941
New +$1.16M
CNA icon
986
CNA Financial
CNA
$13.9B
$1.09M ﹤0.01%
+23,888
New +$1.12M
HOLX
987
DELISTED
Hologic
HOLX
$1.08M ﹤0.01%
16,197
-934,011
-98% -$62.4M
LEN icon
988
Lennar Class A
LEN
$20.6B
$1.07M ﹤0.01%
11,137
+7,346
+194% +$710K
RDUS
989
DELISTED
Radius Recycling
RDUS
$1.07M ﹤0.01%
+21,796
New +$1.08M
GRCL
990
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$1.07M ﹤0.01%
82,369
-1,191
-1% -$15.9K
ORCL icon
991
Oracle
ORCL
$433B
$1.07M ﹤0.01%
13,734
-708,940
-98% -$55.5M
OMIC
992
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$1.07M ﹤0.01%
+1,296
New +$1M
ARVL
993
DELISTED
Arrival Ordinary Shares
ARVL
$1.06M ﹤0.01%
+1,353
New +$1.2M
NVSAW
994
CALL
DELISTED
New Vista Acquisition Corp. Warrant
NVSAW
$1.05M ﹤0.01%
+108,333
New +$96.8K
ALXO icon
995
ALX Oncology
ALXO
$288M
$1.04M ﹤0.01%
+19,093
New +$1.14M
EVH icon
996
Evolent Health
EVH
$460M
$1.04M ﹤0.01%
49,361
-7,695
-13% -$154K
EVR icon
997
Evercore
EVR
$11.5B
$1.04M ﹤0.01%
+7,376
New +$1.03M
ZNGA
998
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$1.04M ﹤0.01%
97,511
-392,285
-80% -$4.13M
PHI icon
999
PLDT
PHI
$4.27B
$1.03M ﹤0.01%
39,399
+21,882
+125% +$582K
PUK icon
1000
Prudential
PUK
$35.1B
$1.03M ﹤0.01%
+27,922
New +$1.14M
38 39
40
41 42

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace North America held 1,984 positions worth $24.1B, down 0.56% from $24.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Marshall Wace North America withdrew a net $2.11B in Q2 2021, closing 587 positions and reducing 445 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $119M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Marshall Wace North America opened a new position in Syneos Health, Inc. Class A Common Stock worth $83.7M.

  • Marshall Wace North America's largest Q2 2021 buy was Syneos Health, Inc. Class A Common Stock: 935,304 shares worth $83.7M.
  • Marshall Wace North America added most to Johnson & Johnson in Q2 2021, an estimated $157M increase.
  • Marshall Wace North America's biggest Q2 2021 reduction was Microsoft, cutting an estimated $313M.
  • Marshall Wace North America fully exited State Street SPDR S&P 500 ETF Trust in Q2 2021, selling an estimated $119M.
  • Marshall Wace North America's ten largest holdings make up 24% of its $24.1B portfolio in Q2 2021.
  • Marshall Wace North America opened 527 new positions and closed 587 in Q2 2021.
  • Marshall Wace North America's portfolio value fell 0.56% quarter-over-quarter to $24.1B.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.